160 related articles for article (PubMed ID: 29310836)
1. Circulating long non-coding RNA MALAT1 expression as molecular biomarker in Egyptian patients with breast cancer.
Zidan HE; Karam RA; El-Seifi OS; Abd Elrahman TM
Cancer Genet; 2018 Jan; 220():32-37. PubMed ID: 29310836
[TBL] [Abstract][Full Text] [Related]
2. Clinical Significance of Long Non-coding RNA MALAT1 Expression in Tissue and Serum of Breast Cancer.
Miao Y; Fan R; Chen L; Qian H
Ann Clin Lab Sci; 2016 Jul; 46(4):418-24. PubMed ID: 27466303
[TBL] [Abstract][Full Text] [Related]
3. High expression of long non-coding RNA MALAT1 in breast cancer is associated with poor relapse-free survival.
Wang Z; Katsaros D; Biglia N; Shen Y; Fu Y; Loo LWM; Jia W; Obata Y; Yu H
Breast Cancer Res Treat; 2018 Sep; 171(2):261-271. PubMed ID: 29845475
[TBL] [Abstract][Full Text] [Related]
4. Large intergenic non-coding RNA-ROR as a potential biomarker for the diagnosis and dynamic monitoring of breast cancer.
Zhao T; Wu L; Li X; Dai H; Zhang Z
Cancer Biomark; 2017 Aug; 20(2):165-173. PubMed ID: 28869448
[TBL] [Abstract][Full Text] [Related]
5. A Panel of Serum Noncoding RNAs for the Diagnosis and Monitoring of Response to Therapy in Patients with Breast Cancer.
Huang SK; Luo Q; Peng H; Li J; Zhao M; Wang J; Gu YY; Li Y; Yuan P; Zhao GH; Huang CZ
Med Sci Monit; 2018 Apr; 24():2476-2488. PubMed ID: 29683112
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA metastasis associated in lung adenocarcinoma transcript 1 (MALAT1) interacts with estrogen receptor and predicted poor survival in breast cancer.
Huang NS; Chi YY; Xue JY; Liu MY; Huang S; Mo M; Zhou SL; Wu J
Oncotarget; 2016 Jun; 7(25):37957-37965. PubMed ID: 27191888
[TBL] [Abstract][Full Text] [Related]
7. [Long non-coding RNA HOTAIR in plasma as a potential biomarker for breast cancer diagnosis].
Zhang KJ; Zhang Y; Luo ZL; Liu L; Yang J; Wu LC; Yu SS; Liu JB
Nan Fang Yi Ke Da Xue Xue Bao; 2016 Apr; 36(4):488-92. PubMed ID: 27113175
[TBL] [Abstract][Full Text] [Related]
8. Serum Long Non-Coding RNAs PVT1, HOTAIR, and NEAT1 as Potential Biomarkers in Egyptian Women with Breast Cancer.
El-Fattah AAA; Sadik NAH; Shaker OG; Mohamed Kamal A; Shahin NN
Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33670447
[TBL] [Abstract][Full Text] [Related]
9. Circulating long non-coding RNA AFAP1-AS1 is a potential diagnostic biomarker for non-small cell lung cancer.
Li W; Li N; Kang X; Shi K
Clin Chim Acta; 2017 Dec; 475():152-156. PubMed ID: 29080690
[TBL] [Abstract][Full Text] [Related]
10. Circulating lncRNA H19 in plasma as a novel biomarker for breast cancer.
Zhang K; Luo Z; Zhang Y; Zhang L; Wu L; Liu L; Yang J; Song X; Liu J
Cancer Biomark; 2016 Jun; 17(2):187-94. PubMed ID: 27540977
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of long non-coding RNA MALAT1 is correlated with clinical progression and unfavorable prognosis in pancreatic cancer.
Pang EJ; Yang R; Fu XB; Liu YF
Tumour Biol; 2015 Apr; 36(4):2403-7. PubMed ID: 25481511
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of long non-coding RNA MALAT1 correlates with tumor progression and poor prognosis in clear cell renal cell carcinoma.
Zhang HM; Yang FQ; Chen SJ; Che J; Zheng JH
Tumour Biol; 2015 Apr; 36(4):2947-55. PubMed ID: 25480417
[TBL] [Abstract][Full Text] [Related]
13. Potential Diagnostic Value of Plasma Long-Chain Non-Coding RNA HIT in Breast Cancer.
Hou H; Li F; Yang W; Wang H
Clin Lab; 2019 Aug; 65(8):. PubMed ID: 31414748
[TBL] [Abstract][Full Text] [Related]
14. Functional and prognostic significance of long non-coding RNA MALAT1 as a metastasis driver in ER negative lymph node negative breast cancer.
Jadaliha M; Zong X; Malakar P; Ray T; Singh DK; Freier SM; Jensen T; Prasanth SG; Karni R; Ray PS; Prasanth KV
Oncotarget; 2016 Jun; 7(26):40418-40436. PubMed ID: 27250026
[TBL] [Abstract][Full Text] [Related]
15. Serum long non-coding RNAs MALAT1, AFAP1-AS1 and AL359062 as diagnostic and prognostic biomarkers for nasopharyngeal carcinoma.
He B; Zeng J; Chao W; Chen X; Huang Y; Deng K; Huang Z; Li J; Dai M; Chen S; Huang H; Dai S
Oncotarget; 2017 Jun; 8(25):41166-41177. PubMed ID: 28467811
[TBL] [Abstract][Full Text] [Related]
16. Circulating DNA of HOTAIR in serum is a novel biomarker for breast cancer.
Zhang L; Song X; Wang X; Xie Y; Wang Z; Xu Y; You X; Liang Z; Cao H
Breast Cancer Res Treat; 2015 Jul; 152(1):199-208. PubMed ID: 26033707
[TBL] [Abstract][Full Text] [Related]
17. Circulating long non-coding HOX transcript antisense intergenic ribonucleic acid in plasma as a potential biomarker for diagnosis of breast cancer.
Zhang Y; Zhang K; Luo Z; Liu L; Wu L; Liu J
Thorac Cancer; 2016 Nov; 7(6):627-632. PubMed ID: 27755794
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA HULC as a novel serum biomarker for diagnosis and prognosis prediction of gastric cancer.
Jin C; Shi W; Wang F; Shen X; Qi J; Cong H; Yuan J; Shi L; Zhu B; Luo X; Zhang Y; Ju S
Oncotarget; 2016 Aug; 7(32):51763-51772. PubMed ID: 27322075
[TBL] [Abstract][Full Text] [Related]
19. Association analyses of a genetic variant in long non-coding RNA MEG3 with breast cancer susceptibility and serum MEG3 expression level in the Egyptian population.
Ali MA; Shaker OG; Alazrak M; AbdelHafez MN; Khalefa AA; Hemeda NF; Abdelmoktader A; Ahmed FA
Cancer Biomark; 2020; 28(1):49-63. PubMed ID: 32176630
[TBL] [Abstract][Full Text] [Related]
20. The lncRNAs Gas5, MALAT1 and SNHG8 as diagnostic biomarkers for epithelial malignant pleural mesothelioma in Egyptian patients.
Elkahwagy DM; Kiriacos CJ; Sobeih ME; Khorshid OMR; Mansour M
Sci Rep; 2024 Feb; 14(1):4823. PubMed ID: 38413635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
